Horien Biochemical Technology Co (ROCO:7814) Net Margin %: 18.83% (As of Dec. 2025) — 188% Above Median


ROCO:7814 Horien Biochemical Technology Co Ltd ROCO:7814
21 GF Score
Price NT$38.65
! 5 Warning Signs
View Full Analysis

What is Horien Biochemical Technology Co Net Margin %?

Horien Biochemical Technology Co ROCO:7814 -6.53% 21 Net Margin % is 18.83% as of Dec. 2025, which is 188% above its 10-year median of 6.53. GuruFocus rates ROCO:7814 with a GF Score™ of 21/100. The stock has 5 warning signs investors should review. Among 944 Biotechnology companies, Horien Biochemical Technology Co ranks better than 84.43% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Horien Biochemical Technology Co's Net Income for the three months ended in Dec. 2025 was NT$5.18 Mil. Horien Biochemical Technology Co's Revenue for the three months ended in Dec. 2025 was NT$27.52 Mil. Therefore, Horien Biochemical Technology Co's net margin for the quarter that ended in Dec. 2025 was 18.83%.

The historical rank and industry rank for Horien Biochemical Technology Co's Net Margin % or its related term are showing as below:

ROCO:7814' s Net Margin % Range Over the Past 10 Years
Min: -6.03   Med: 6.53   Max: 22.77
Current: 15.43

ROCO:7814's Net Margin % is ranked better than
84.43% of 944 companies
in the Biotechnology industry
Industry Median: -88.815 vs ROCO:7814: 15.43

Horien Biochemical Technology Co  (ROCO:7814) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Horien Biochemical Technology Co Net Margin % Related Terms

Horien Biochemical Technology Co Net Margin % Historical Data

* Premium members only.

The historical data trend for Horien Biochemical Technology Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Horien Biochemical Technology Co Net Margin % Chart

Horien Biochemical Technology Co Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Net Margin %
5.02 22.77 8.04 -6.03

Horien Biochemical Technology Co Quarterly Data
Dec22 Dec23 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
Net Margin % Get a 7-Day Free Trial 41.87 24.49 0.00 11.62 18.83

ROCO:7814 vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, Horien Biochemical Technology Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Horien Biochemical Technology Co Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Horien Biochemical Technology Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Horien Biochemical Technology Co's Net Margin % falls into.


ROCO:7814
21GF Score
Horien Biochemical Technology Co Ltd ROCO:7814
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Horien Biochemical Technology Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Horien Biochemical Technology Co's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-5.004/83.043
=-6.03 %

Horien Biochemical Technology Co's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=5.183/27.523
=18.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 18.83% mean?
Horien Biochemical Technology Co (ROCO:7814) has a Net Margin % of 18.83% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Horien Biochemical Technology Co and its competitors. This is 188% above median its historical median of 6.53. According to the industry distribution chart, Horien Biochemical Technology Co ranks #147 out of 944 companies in the Biotechnology industry, placing it in the top 15.6%.
Is Horien Biochemical Technology Co's Net Margin % too high?
Horien Biochemical Technology Co's current Net Margin % of 18.83% is 188% above median its 10-year median of 6.53. Based on the distribution chart, Horien Biochemical Technology Co ranks #147 out of 944 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Horien Biochemical Technology Co has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Horien Biochemical Technology Co's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Horien Biochemical Technology Co ranks #147 out of 944 companies for Net Margin %. This places Horien Biochemical Technology Co in the top 16% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Horien Biochemical Technology Co and its competitors. Horien Biochemical Technology Co's current Net Margin % is 18.83%, which is 188% above median its own 10-year median of 6.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Horien Biochemical Technology Co stock overvalued right now?
Horien Biochemical Technology Co (ROCO:7814) has a current Net Margin % of 18.83%. The current Net Margin % is 18.83%, which is 188% above median its 10-year median of 6.53. Horien Biochemical Technology Co's overall GF Score™ is 21/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Horien Biochemical Technology Co (ROCO:7814), the current Net Margin % is 18.83% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Horien Biochemical Technology Co Business Description

Address Gongyecyu 38th Road, 7F-5 & 6, NO. 210, Situn District, Siehe Village, Taichung, TWN, 40768
Horien Biochemical Technology Co Ltd is engaged in the research and development of cosmetic raw materials and medical devices and facilities. The products of the company include Gen-Nusis, skin repairment ingredients, PeptioMax, the latest cosmetic raw material, Lifkin, and other substitutes used in dentistry and general surgery.
21GF Score

Get the complete analysis for ROCO:7814

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$38.65
Price